MoneyWorks4Me

Net sales declined -21.58%  to  Rs. 434.86 million from Rs. 554.51 millions.The Net Profit of the company slipped to Rs. 35.49 millions from Rs. 56.02 millions, a decline of -36.65% on QoQ basis.Operating profit for the quarter ended March 2024 decreased to 51.56 millions as compared to 79.96 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 434.86 554.51 -21.58 2087.02 2367.14 -11.83 2087.02 2367.14 -11.83
Other Income 24.87 25.59 -2.81 92.79 57.34 61.82 92.79 57.34 61.82
PBIDT 51.56 79.96 -35.52 323.46 398.85 -18.90 323.46 398.85 -18.90
Interest 2.17 1.96 10.71 8.14 4.13 97.09 8.14 4.13 97.09
PBDT 49.39 78.00 -36.68 315.32 360.13 -12.44 315.32 360.13 -12.44
Depreciation 4.03 4.79 -15.87 16.63 12.05 38.01 16.63 12.05 38.01
PBT 45.36 73.21 -38.04 298.69 348.08 -14.19 298.69 348.08 -14.19
TAX 9.87 17.19 -42.58 74.06 80.87 -8.42 74.06 80.87 -8.42
Deferred Tax -0.17 1.79 -109.50 -1.54 4.55 -133.85 -1.54 4.55 -133.85
PAT 35.49 56.02 -36.65 224.63 267.21 -15.94 224.63 267.21 -15.94
Equity 132.19 130.99 0.92 132.19 130.99 0.92 132.19 130.99 0.92
PBIDTM(%) 11.86 14.42 -17.78 15.50 16.85 -8.02 15.50 16.85 -8.02
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..